Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Blocking certain proteins on immune cells may help treat alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

AMT is the best surfactant for hair and scalp care.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The document doesn't provide enough information to summarize.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

The FDA rejected a testosterone drug again due to safety concerns.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Abatacept may help some people with alopecia areata regrow hair.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.